Chapter/Section Purchase

1 Study Coverage
1.1 Parkinsons Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Parkinsons Disease Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parkinsons Disease Drug Sales by Region
2.4.1 Global Parkinsons Disease Drug Sales by Region (2017-2022)
2.4.2 Global Sales Parkinsons Disease Drug by Region (2023-2028)
2.5 Global Parkinsons Disease Drug Revenue by Region
2.5.1 Global Parkinsons Disease Drug Revenue by Region (2017-2022)
2.5.2 Global Parkinsons Disease Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parkinsons Disease Drug Sales by Manufacturers
3.1.1 Global Top Parkinsons Disease Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drug in 2021
3.2 Global Parkinsons Disease Drug Revenue by Manufacturers
3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drug Revenue in 2021
3.3 Global Parkinsons Disease Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parkinsons Disease Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parkinsons Disease Drug Sales by Type
4.1.1 Global Parkinsons Disease Drug Historical Sales by Type (2017-2022)
4.1.2 Global Parkinsons Disease Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
4.2 Global Parkinsons Disease Drug Revenue by Type
4.2.1 Global Parkinsons Disease Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
4.3 Global Parkinsons Disease Drug Price by Type
4.3.1 Global Parkinsons Disease Drug Price by Type (2017-2022)
4.3.2 Global Parkinsons Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parkinsons Disease Drug Sales by Application
5.1.1 Global Parkinsons Disease Drug Historical Sales by Application (2017-2022)
5.1.2 Global Parkinsons Disease Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
5.2 Global Parkinsons Disease Drug Revenue by Application
5.2.1 Global Parkinsons Disease Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
5.3 Global Parkinsons Disease Drug Price by Application
5.3.1 Global Parkinsons Disease Drug Price by Application (2017-2022)
5.3.2 Global Parkinsons Disease Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinsons Disease Drug Market Size by Type
6.1.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
6.1.2 North America Parkinsons Disease Drug Revenue by Type (2017-2028)
6.2 North America Parkinsons Disease Drug Market Size by Application
6.2.1 North America Parkinsons Disease Drug Sales by Application (2017-2028)
6.2.2 North America Parkinsons Disease Drug Revenue by Application (2017-2028)
6.3 North America Parkinsons Disease Drug Market Size by Country
6.3.1 North America Parkinsons Disease Drug Sales by Country (2017-2028)
6.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Parkinsons Disease Drug Market Size by Type
7.1.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
7.1.2 Europe Parkinsons Disease Drug Revenue by Type (2017-2028)
7.2 Europe Parkinsons Disease Drug Market Size by Application
7.2.1 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
7.2.2 Europe Parkinsons Disease Drug Revenue by Application (2017-2028)
7.3 Europe Parkinsons Disease Drug Market Size by Country
7.3.1 Europe Parkinsons Disease Drug Sales by Country (2017-2028)
7.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinsons Disease Drug Market Size by Type
8.1.1 Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Parkinsons Disease Drug Market Size by Application
8.2.1 Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Parkinsons Disease Drug Market Size by Region
8.3.1 Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parkinsons Disease Drug Market Size by Type
9.1.1 Latin America Parkinsons Disease Drug Sales by Type (2017-2028)
9.1.2 Latin America Parkinsons Disease Drug Revenue by Type (2017-2028)
9.2 Latin America Parkinsons Disease Drug Market Size by Application
9.2.1 Latin America Parkinsons Disease Drug Sales by Application (2017-2028)
9.2.2 Latin America Parkinsons Disease Drug Revenue by Application (2017-2028)
9.3 Latin America Parkinsons Disease Drug Market Size by Country
9.3.1 Latin America Parkinsons Disease Drug Sales by Country (2017-2028)
9.3.2 Latin America Parkinsons Disease Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons Disease Drug Market Size by Type
10.1.1 Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Parkinsons Disease Drug Market Size by Application
10.2.1 Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Parkinsons Disease Drug Market Size by Country
10.3.1 Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Overview
11.4.3 AbbVie Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AbbVie Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Overview
11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Impax Laboratories Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Corporation Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lundbeck Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Corporation Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharma Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Corporation Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wockhardt Recent Developments
11.11 UCB
11.11.1 UCB Corporation Information
11.11.2 UCB Overview
11.11.3 UCB Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UCB Recent Developments
11.12 Bausch Health
11.12.1 Bausch Health Corporation Information
11.12.2 Bausch Health Overview
11.12.3 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bausch Health Recent Developments
11.13 Acadia
11.13.1 Acadia Corporation Information
11.13.2 Acadia Overview
11.13.3 Acadia Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Acadia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parkinsons Disease Drug Industry Chain Analysis
12.2 Parkinsons Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinsons Disease Drug Production Mode & Process
12.4 Parkinsons Disease Drug Sales and Marketing
12.4.1 Parkinsons Disease Drug Sales Channels
12.4.2 Parkinsons Disease Drug Distributors
12.5 Parkinsons Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parkinsons Disease Drug Industry Trends
13.2 Parkinsons Disease Drug Market Drivers
13.3 Parkinsons Disease Drug Market Challenges
13.4 Parkinsons Disease Drug Market Restraints
14 Key Findings in The Global Parkinsons Disease Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer